HCA Healthcare (HCA)
(Delayed Data from NYSE)
$339.75 USD
+4.65 (1.39%)
Updated May 31, 2024 04:00 PM ET
After-Market: $339.70 -0.05 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$339.75 USD
+4.65 (1.39%)
Updated May 31, 2024 04:00 PM ET
After-Market: $339.70 -0.05 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Zacks News
What's in the Cards for HCA Healthcare (HCA) in Q3 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 results are likely to be aided by strong revenues, driven by higher admissions.
HCA Holdings (HCA) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
Why HCA (HCA) Could Beat Earnings Estimates Again
by Zacks Equity Research
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MEDNAX Buys Radiology Specialists to Expand Business
by Zacks Equity Research
MEDNAX (MD) boosts its radiology business with the acquisition of Radiology Specialists.
Community Health's (CYH) Subsidiary to Clear Fraud Charges
by Zacks Equity Research
Community Health Systems' (CYH) arm to settle whistleblower lawsuits alleging a wide-ranging misconduct in emergency rooms.
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
Should Value Investors Pick HCA Healthcare (HCA) Stock Now?
by Zacks Equity Research
Let's see if HCA Healthcare, Inc. (HCA) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Zacks.com highlights: G-III Apparel Group, HCA Healthcare, US Ecology, Penumbra and North American Construction Group
by Zacks Equity Research
Zacks.com highlights: G-III Apparel Group, HCA Healthcare, US Ecology, Penumbra and North American Construction Group
Brave Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
We create a strategy that shows less risky stocks could also be rewarding if some parameters are considered.
US-China Trade Conflict Intensifies: 5 Low-Beta Stock Picks
by Nalak Das
Ongoing trade conflicts between the United States and China, which started in March, is showing no signs of abatement.
Are Options Traders Betting on a Big Move in HCA Healthcare (HCA) Stock?
by Zacks Equity Research
Investors need to pay close attention to HCA Healthcare (HCA) stock based on the movements in the options market lately.
New Strong Buy Stocks for September 17th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Will Hurricane Florence Hurt LifePoint's Patient Volumes?
by Zacks Equity Research
LifePoint's (LPNT) exposure to Carolina might lead to decline in patient visits, possibly hurting business volumes.
New Strong Buy Stocks for September 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
HCA Healthcare to Buy Mission Health for Portfolio Boost
by Zacks Equity Research
HCA Healthcare (HCA) to buy Mission Health for bracing its service portfolio and serve the people of western North Carolina in a better way.
Zacks Investment Ideas feature highlights: HCA, WellCare and Molina
by Zacks Equity Research
Zacks Investment Ideas feature highlights: HCA, WellCare and Molina
S&P 500 Hits 2,900: Best Performing Stocks YTD
by Sweta Killa
While there are winners from various corners of the space, we have highlighted five stocks on the S&P 500 that have outperformed so far this year.
Top-Ranked Health Care Companies Delivering Steady Growth
by David Borun
These firms are aggressively managing costs and benefit from a demographic shift in health care spending
HCA Healthcare Up 11% Since Q2, Will the Rally Continue?
by Zacks Equity Research
HCA Healthcare's (HCA) shares rallied led by strong second-quarter results.
There are 3 HOT Sectors to Know About!
by John Blank
What stock sectors keep the S&P500 on the move higher?
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
Buy These 5 Low-Beta Stocks to Brave Market Volatility
by Zacks Equity Research
In this article, we have come up with an investment strategy that clearly shows that less risky securities can also generate handsome returns if some parameters are considered.
New Strong Buy Stocks for August 20th
by Gourav Kanti Bagchi
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Looking for Value? Why It Might Be Time to Try HCA Healthcare (HCA)
by Zacks Equity Research
HCA Healthcare (HCA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.